Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jevcampe
    Member
    • Apr 2013
    • 13

    #1

    Blastx similarity %

    Dear all,

    I have performed a blastx on my 30.000 contigs of my transcriptome.
    I want to keep only the contigs for which the sequence description (output of blast2go) is reliable. i often see papers in which people only use a e-value cut off or a bit score cut off. Using this, I still have contigs with hits with a similarity of 40% that are not removed. I'm convinced that this is insufficient to trust the sequence description and to continue with GO, KEGG pathways and any furhter downstream application.
    I would like to use a similarity cut off to reliable say that the contig is in fact the gene and related function of the blast results. Does anybody know what a good cut off value might be? Or how to proceed.
    I have yet to encounter a paper where people really adress the low similarity problem. If you would have any suggestions feel free to share.

    Cheers,
  • kurban910
    Member
    • Jul 2014
    • 58

    #2
    hello jevcampe,
    did u solve your problem? if u did, what is the cut off you chose for similarity?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      Yesterday, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:52 AM
    0 responses
    8 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 05:39 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...